280 related articles for article (PubMed ID: 37318776)
1. Advances in pharmacotherapies for axial spondyloarthritis.
Toussirot E
Expert Opin Pharmacother; 2023; 24(13):1439-1448. PubMed ID: 37318776
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological management of axial spondyloarthritis in adults.
Toussirot E
Expert Opin Pharmacother; 2019 Aug; 20(12):1483-1491. PubMed ID: 31095430
[No Abstract] [Full Text] [Related]
3. Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis.
Webers C; Ortolan A; Sepriano A; Falzon L; Baraliakos X; Landewé RBM; Ramiro S; van der Heijde D; Nikiphorou E
Ann Rheum Dis; 2023 Jan; 82(1):130-141. PubMed ID: 36270657
[TBL] [Abstract][Full Text] [Related]
4. Management of Axial Spondyloarthritis - Insights into Upadacitinib.
Braun J; Kiltz U; Baraliakos X
Drug Des Devel Ther; 2022; 16():3609-3620. PubMed ID: 36268520
[TBL] [Abstract][Full Text] [Related]
5. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update.
Ramiro S; Nikiphorou E; Sepriano A; Ortolan A; Webers C; Baraliakos X; Landewé RBM; Van den Bosch FE; Boteva B; Bremander A; Carron P; Ciurea A; van Gaalen FA; Géher P; Gensler L; Hermann J; de Hooge M; Husakova M; Kiltz U; López-Medina C; Machado PM; Marzo-Ortega H; Molto A; Navarro-Compán V; Nissen MJ; Pimentel-Santos FM; Poddubnyy D; Proft F; Rudwaleit M; Telkman M; Zhao SS; Ziade N; van der Heijde D
Ann Rheum Dis; 2023 Jan; 82(1):19-34. PubMed ID: 36270658
[TBL] [Abstract][Full Text] [Related]
6. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).
Kroon FP; van der Burg LR; Ramiro S; Landewé RB; Buchbinder R; Falzon L; van der Heijde D
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010952. PubMed ID: 26186173
[TBL] [Abstract][Full Text] [Related]
7. Upadacitinib for the treatment of adults with active non-radiographic axial spondyloarthritis (nr-axSpA).
Fukui S; Kawaai S; Sawada H; Kishimoto M
Expert Rev Clin Immunol; 2024 Feb; 20(2):141-153. PubMed ID: 37955181
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials.
van der Heijde D; Deodhar A; Baraliakos X; Brown MA; Dobashi H; Dougados M; Elewaut D; Ellis AM; Fleurinck C; Gaffney K; Gensler LS; Haroon N; Magrey M; Maksymowych WP; Marten A; Massow U; Oortgiesen M; Poddubnyy D; Rudwaleit M; Shepherd-Smith J; Tomita T; Van den Bosch F; Vaux T; Xu H
Ann Rheum Dis; 2023 Apr; 82(4):515-526. PubMed ID: 36649967
[TBL] [Abstract][Full Text] [Related]
9. Certolizumab pegol for treating axial spondyloarthritis.
Desmarais J; Beier S; Deodhar A
Expert Opin Biol Ther; 2016 Aug; 16(8):1059-64. PubMed ID: 27366922
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.
Ortolan A; Webers C; Sepriano A; Falzon L; Baraliakos X; Landewé RB; Ramiro S; van der Heijde D; Nikiphorou E
Ann Rheum Dis; 2023 Jan; 82(1):142-152. PubMed ID: 36261247
[TBL] [Abstract][Full Text] [Related]
11. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.
van der Heijde D; Ramiro S; Landewé R; Baraliakos X; Van den Bosch F; Sepriano A; Regel A; Ciurea A; Dagfinrud H; Dougados M; van Gaalen F; Géher P; van der Horst-Bruinsma I; Inman RD; Jongkees M; Kiltz U; Kvien TK; Machado PM; Marzo-Ortega H; Molto A; Navarro-Compàn V; Ozgocmen S; Pimentel-Santos FM; Reveille J; Rudwaleit M; Sieper J; Sampaio-Barros P; Wiek D; Braun J
Ann Rheum Dis; 2017 Jun; 76(6):978-991. PubMed ID: 28087505
[TBL] [Abstract][Full Text] [Related]
12. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
Lopalco G; Venerito V; Cantarini L; Emmi G; Salaffi F; Di Carlo M; Tafuri S; Gentileschi S; Di Scala G; Nivuori M; Cacciapaglia F; Galeazzi M; Lapadula G; Iannone F
Clin Exp Rheumatol; 2019; 37(5):762-767. PubMed ID: 31025925
[TBL] [Abstract][Full Text] [Related]
13. Efficiency of treatment with non-steroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis.
Baraliakos X; Kiltz U; Peters S; Appel H; Dybowski F; Igelmann M; Kalthoff L; Krause D; Menne HJ; Saracbasi-Zender E; Schmitz-Bortz E; Vigneswaran M; Braun J
Rheumatology (Oxford); 2017 Jan; 56(1):95-102. PubMed ID: 27997346
[TBL] [Abstract][Full Text] [Related]
14. Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort.
Ciurea A; Kissling S; Bürki K; Baraliakos X; de Hooge M; Hebeisen M; Papagiannoulis E; Exer P; Bräm R; Nissen MJ; Möller B; Kyburz D; Andor M; Distler O; Scherer A; Micheroli R
RMD Open; 2022 Feb; 8(1):. PubMed ID: 35110365
[TBL] [Abstract][Full Text] [Related]
15. Axial Spondyloarthritis in Japan.
Kameda H; Kishimoto M; Kobayashi S; Tomita T; Morita A; Yamamura M
Curr Rheumatol Rep; 2022 May; 24(5):149-155. PubMed ID: 35380380
[TBL] [Abstract][Full Text] [Related]
16. Radiographic progression in non-radiographic axial spondyloarthritis.
Protopopov M; Poddubnyy D
Expert Rev Clin Immunol; 2018 Jun; 14(6):525-533. PubMed ID: 29774755
[TBL] [Abstract][Full Text] [Related]
17. Have Therapeutics Enhanced Our Knowledge of Axial Spondyloarthritis?
Harrison SR; Marzo-Ortega H
Curr Rheumatol Rep; 2023 Mar; 25(3):56-67. PubMed ID: 36652160
[TBL] [Abstract][Full Text] [Related]
18. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
Malaviya AN; Kalyani A; Rawat R; Gogia SB
Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
[TBL] [Abstract][Full Text] [Related]
19. Nonradiographic axial spondyloarthritis: expanding the spectrum of an old disease: A narrative review.
Magrey M; Schwartzman S; de Peyrecave N; Sloan VS; Stark JL
Medicine (Baltimore); 2022 Apr; 101(15):e29063. PubMed ID: 35475794
[TBL] [Abstract][Full Text] [Related]
20. Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry.
Glintborg B; Sørensen IJ; Østergaard M; Dreyer L; Mohamoud AA; Krogh NS; Hendricks O; Andersen LS; Raun JL; Kowalski MR; Danielsen L; Pelck R; Nordin H; Pedersen JK; Kraus DG; Christensen SR; Hansen IM; Esbesen J; Schlemmer A; Loft AG; Al Chaer N; Salomonsen L; Hetland ML
J Rheumatol; 2017 Jan; 44(1):59-69. PubMed ID: 27909080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
